Cargando…
NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
NDV-3A, a novel fungal vaccine undergoing clinical trials, contains a recombinant version of the Candida albicans rAls3 N-terminus protein (rAls3p-N) in aluminum hydroxide. In a Phase 1b/2a clinical trial, NDV-3A protected women from recurrent vulvovaginal candidiasis. Here, we reveal that active im...
Autores principales: | Alqarihi, Abdullah, Singh, Shakti, Edwards, John E., Ibrahim, Ashraf S., Uppuluri, Priya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470131/ https://www.ncbi.nlm.nih.gov/pubmed/30996274 http://dx.doi.org/10.1038/s41598-019-42517-y |
Ejemplares similares
-
The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection
por: Singh, Shakti, et al.
Publicado: (2019) -
Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
por: Uppuluri, Priya, et al.
Publicado: (2018) -
An evolutionarily diverged mitochondrial protein controls biofilm growth and virulence in Candida albicans
por: Mamouei, Zeinab, et al.
Publicado: (2021) -
Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis
por: Singh, Shakti, et al.
Publicado: (2022) -
Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
por: Mamouei, Zeinab, et al.
Publicado: (2018)